tiprankstipranks
Advertisement
Advertisement
Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged
PremiumCompany AnnouncementsTandem Diabetes Care Announces Leadership Change, Strategy Unchanged
14d ago
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
Premium
The Fly
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
17d ago
Tandem Diabetes initiated with a Hold at Benchmark
Premium
The Fly
Tandem Diabetes initiated with a Hold at Benchmark
17d ago
Tandem Diabetes price target raised to $24 from $22 at Mizuho
PremiumThe FlyTandem Diabetes price target raised to $24 from $22 at Mizuho
21d ago
Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained
22d ago
Tandem Diabetes reports Q1 EPS (30c), consensus (44c)
Premium
The Fly
Tandem Diabetes reports Q1 EPS (30c), consensus (44c)
22d ago
Tandem Diabetes price target raised to $28 from $25 at TD Cowen
PremiumThe FlyTandem Diabetes price target raised to $28 from $25 at TD Cowen
1M ago
Tandem Diabetes price target raised to $28 from $25 at TD Cowen
Premium
The Fly
Tandem Diabetes price target raised to $28 from $25 at TD Cowen
1M ago
Leveraging Rx Channel Shift and Mobi Tubeless Launch to Drive Sustainable Growth at Tandem Diabetes Care
Premium
Ratings
Leveraging Rx Channel Shift and Mobi Tubeless Launch to Drive Sustainable Growth at Tandem Diabetes Care
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100